• Je něco špatně v tomto záznamu ?

Serum levels of soluble adhesion molecules in newly diagnosed acute myeloid leukemia and in complete remission suggest endothelial cell activation by myeloblasts

T. Kupsa, J. Vanek, Z. Pavel, L. Jebavy, J. M. Horacek

. 2017 ; 161 (1) : 92-99. [pub] 20161110

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17032089

BACKGROUND AND AIMS: Despite high-dose multi-agent chemotherapy and allogeneic stem cell transplantation, the relapse rate of acute myeloid leukemia (AML) is high. Further, the disease is highly resistent to drugs. We speculated that deeper understanding of AML-endothelial cell interactions might provide new targets for selective modulation of the AML microenvironment and form the basis for novel treatment approaches. In this study, we evaluated levels of endothelium derived soluble adhesion molecules in active disease and in complete remission (CR) and their relationship with inflammatory cytokines. METHODS: Baseline serum levels of 25 cytokines and 5 soluble adhesion molecules were measured in 84 AML patients using biochip array technology. CR samples were evaluated in 44 patients of this cohort. The control group consisted of 15 healthy blood donors. RESULTS: All analytes were independent of age or disease origin. Some correlations were restricted to active AML, some were ubiquitous and some were found in remission. In active disease, E-selectin (E-SEL) and VCAM-1 correlated with leukocyte count, E-SEL correlated with P-selectin (P-SEL). Platelet count related to IL-7, EGF and VEGF but not to P-SEL. In CR, P-SEL correlated with platelet count and EGF but not with E-SEL. There was no relationship of P-SEL and E-SEL in the control group. CONCLUSIONS: Leukemic activity is associated with a different pattern of soluble adhesion molecule levels. Both E-SEL and P-SEL may be derived from endothelial cells. Their levels correlated in active disease. E-SEL correlated with leukocyte count. In CR, P-SEL physiologically correlated with platelet count. The correlation with E-SEL was insignificant and absent in the control group. Our data suggest activation of endothelial cells in the presence of myeloblasts.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17032089
003      
CZ-PrNML
005      
20200211141212.0
007      
ta
008      
171025s2017 xr f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2016.054 $2 doi
035    __
$a (PubMed)27833171
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Kupsa, Tomáš $u Department of Military Internal Medicine and Military Hygiene, University of Defence, Faculty of Military Health Sciences (FMHS), Hradec Kralove, Czech Republic; 4th Department of Internal Medicine - Hematology, University Hospital Hradec Kralove, Czech Republic $7 xx0267991
245    10
$a Serum levels of soluble adhesion molecules in newly diagnosed acute myeloid leukemia and in complete remission suggest endothelial cell activation by myeloblasts / $c T. Kupsa, J. Vanek, Z. Pavel, L. Jebavy, J. M. Horacek
520    9_
$a BACKGROUND AND AIMS: Despite high-dose multi-agent chemotherapy and allogeneic stem cell transplantation, the relapse rate of acute myeloid leukemia (AML) is high. Further, the disease is highly resistent to drugs. We speculated that deeper understanding of AML-endothelial cell interactions might provide new targets for selective modulation of the AML microenvironment and form the basis for novel treatment approaches. In this study, we evaluated levels of endothelium derived soluble adhesion molecules in active disease and in complete remission (CR) and their relationship with inflammatory cytokines. METHODS: Baseline serum levels of 25 cytokines and 5 soluble adhesion molecules were measured in 84 AML patients using biochip array technology. CR samples were evaluated in 44 patients of this cohort. The control group consisted of 15 healthy blood donors. RESULTS: All analytes were independent of age or disease origin. Some correlations were restricted to active AML, some were ubiquitous and some were found in remission. In active disease, E-selectin (E-SEL) and VCAM-1 correlated with leukocyte count, E-SEL correlated with P-selectin (P-SEL). Platelet count related to IL-7, EGF and VEGF but not to P-SEL. In CR, P-SEL correlated with platelet count and EGF but not with E-SEL. There was no relationship of P-SEL and E-SEL in the control group. CONCLUSIONS: Leukemic activity is associated with a different pattern of soluble adhesion molecule levels. Both E-SEL and P-SEL may be derived from endothelial cells. Their levels correlated in active disease. E-SEL correlated with leukocyte count. In CR, P-SEL physiologically correlated with platelet count. The correlation with E-SEL was insignificant and absent in the control group. Our data suggest activation of endothelial cells in the presence of myeloblasts.
650    _2
$a C-reaktivní protein $x metabolismus $7 D002097
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a molekuly buněčné adheze $x metabolismus $7 D015815
650    _2
$a cytokiny $x metabolismus $7 D016207
650    _2
$a endoteliální buňky $x fyziologie $7 D042783
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a prekurzorové buňky granulocytů $x fyziologie $7 D042381
650    _2
$a lidé $7 D006801
650    _2
$a akutní myeloidní leukemie $x krev $7 D015470
650    _2
$a počet leukocytů $7 D007958
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a indukce remise $7 D012074
650    _2
$a vaskulární endoteliální růstový faktor A $x metabolismus $7 D042461
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vaněk, Jan, $u Department of Informatics and Quantitative Methods, Faculty of Informatics and Management, University of Hradec Kralove, Hradec Kralove, Czech Republic $d 1978- $7 xx0114510
700    1_
$a Žák, Pavel, $u 4th Department of Internal Medicine - Hematology, University Hospital Hradec Kralove, Czech Republic; 4th Department of Internal Medicine - Hematology, Faculty of Medicine, Charles University in Prague, Hradec Kralove, Czech Republic $d 1966- $7 mzk2006354145
700    1_
$a Jebavý, Ladislav, $u Department of Military Internal Medicine and Military Hygiene, University of Defence, Faculty of Military Health Sciences (FMHS), Hradec Kralove, Czech Republic; 4th Department of Internal Medicine - Hematology, University Hospital Hradec Kralove, Czech Republic $d 1950- $7 mzk2007408362
700    1_
$a Horáček, Jan $u Department of Military Internal Medicine and Military Hygiene, University of Defence, Faculty of Military Health Sciences (FMHS), Hradec Kralove, Czech Republic; 4th Department of Internal Medicine - Hematology, University Hospital Hradec Kralove, Czech Republic $7 xx0040415
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic $x 1213-8118 $g Roč. 161, č. 1 (2017), s. 92-99
910    __
$a ABA008 $b A 1502 $c 958 $y 4 $z 0
990    __
$a 20171025 $b ABA008
991    __
$a 20200211141606 $b ABA008
999    __
$a ok $b bmc $g 1267913 $s 993116
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 161 $c 1 $d 92-99 $e 20161110 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK118 $a Pubmed-20171025

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace